Andrew Potter

Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening

Nicolas Foloppe, Lisa M. Fisher, Rob Howes et al. · Bioorganic & Medicinal Chemistry · 2006 · 359 citations · Full text

Medicinal Chemistry, Virtual Screening, Hit Identification +8

Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class

Jean Kim, Tiffany Farchione, Andrew Potter et al. · New England Journal of Medicine · 2019 · 323 citations

Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial

Martin Dennis, Gillian Mead, John Forbes et al. · The Lancet · 2018 · 276 citations · Full text

Rational Design of Inhibitors of HIV-1 TAR RNA through the Stabilisation of Electrostatic “Hot Spots”

Ben Davis, Mohammad Afshar, Gabriele Varani et al. · Journal of Molecular Biology · 2004 · 152 citations

Biochemistry, Rational Design, Natural Sciences +9

Structure-based Drug Design Targeting an Inactive RNA Conformation: Exploiting the Flexibility of HIV-1 TAR RNA

Alastair I.H. Murchie, Ben Davis, Catherine Isel et al. · Journal of Molecular Biology · 2003 · 140 citations

Engineering, Protein Folding, Rna Structure Prediction +12